Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study

Introduction For people with type 2 diabetes mellitus (T2DM) who require an antidiabetic drug as an add-on to metformin, there is controversy about whether newer drug classes such as dipeptidyl peptidase-4 inhibitors (DPP4i) or sodium-glucose co-transporter-2 inhibitors (SGLT2i) reduce the risk of l...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamlesh Khunti, Samantha Wilkinson, Liam Smeeth, Laurie A Tomlinson, Amanda I Adler, Ian J Douglas, Andrew Briggs, Richard Grieve, Stephen O’neill, Richard J Silverwood, Paul Charlton, Patrick Bidulka, Anirban Basu
Format: Article
Language:English
Published: BMJ Publishing Group 2021-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/9/e046912.full
Tags: Add Tag
No Tags, Be the first to tag this record!